Clinical Trials Directory

Trials / Terminated

TerminatedNCT02597504

Development of a Neurocognitive Screening Test

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
1,600 (actual)
Sponsor
ImPACT Applications, Inc. · Industry
Sex
All
Age
6 Years – 75 Years
Healthy volunteers
Accepted

Summary

This research study will evaluate a standalone software application and is designed to standardize and validate new neurocognitive screening testing for children aged 6 through 11, and adolescents and adults ages 12 through 75. The purpose of this study is to evaluate recently developed computerized tasks sensitive to changes in neurocognitive performance after a concussion. These tests were designed to help measure the effects of concussion on cognitive processes (e.g., memory, attention, brain speed) and visual functioning.

Conditions

Interventions

TypeNameDescription
OTHERPen and paper neuropsychological testWill be administered for Construct Validity to determine agreement with Quick Test
DEVICEQuick TestQuick Test, computerized test will be administered to all subjects.

Timeline

Start date
2015-10-01
Primary completion
2019-10-01
Completion
2019-10-01
First posted
2015-11-05
Last updated
2023-09-29

Locations

4 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT02597504. Inclusion in this directory is not an endorsement.